Summary
CME Group Inc. (CME) filed an 8-K on February 4, 2002, to disclose important details regarding its upcoming 2002 Annual Meeting of Shareholders, scheduled for April 17, 2002. The primary focus of the filing is the announcement of director nominees and a proposed charter amendment. This meeting marks a significant step in the company's previously announced two-step demutualization process, aiming to further reduce the size of the Board of Directors from 30 to 19 members as mandated by its charter. Investors should note the proposed charter amendment, which seeks to increase the Class A/B Director positions by one to ensure management representation on the streamlined board, with the CEO nominated to fill this role. The filing also outlines the nominees selected by various nominating committees for different director classes, including Class A/B Directors, Class B-1 Directors (CME Division), and Class B-2 Directors (IMM Division). A petitioning process for additional director nominations is also detailed, with a deadline of February 15, 2002, for submissions.
Key Highlights
- 1CME Group Inc. has set April 17, 2002, as the date for its Annual Meeting of Shareholders.
- 2The company plans to further reduce its Board of Directors size from 30 to 19 members as part of its demutualization process.
- 3A proposed charter amendment will be presented to increase the number of Class A/B Directors by one to facilitate management representation.
- 4The company's CEO, Jim McNulty, is nominated to fill the potential new Class A/B Director position.
- 5Nominees for various director classes (Class A/B, Class B-1, Class B-2) have been announced.
- 6A petitioning process is in place for shareholders to nominate additional directors for the CME and IMM Divisions, with a submission deadline of February 15, 2002.
- 7Investors will receive a proxy statement with detailed information about the proposals and nominees prior to the meeting.